Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Sebastian M. Dieter, Christoph Heining, Abbas Agaimy, Daniel Hüebschmann, David Bonekamp, Barbara Hutter, Karl Roland Ehrenberg, Martina Fröhlich, Matthias Schlesner, Claudia Scholl, Hp Schlemmer, Stephan Wolf, Athanasios Mavratzas, Chan-soo Jung, Stefan Gröschel, Christof von Kalle, Roland Eils, Benedikt Brors, Roland Penzel, Mark Kriegsmann, David Reuß, Peter Schirmacher, Albrecht Stenzinger, P. Federspil, Wilko Weichert, Hanno Glimm, Stefan FröhlingAnnals 2016 · DOI

BibTeX
@article{dieter2016mutant,
  author = {Sebastian M. Dieter and Christoph Heining and Abbas Agaimy and Daniel Hüebschmann and David Bonekamp and Barbara Hutter and Karl Roland Ehrenberg and Martina Fröhlich and Matthias Schlesner and Claudia Scholl and HP Schlemmer and Stephan Wolf and Athanasios Mavratzas and Chan-soo Jung and Stefan Gröschel and Christof von Kalle and Roland Eils and Benedikt Brors and Roland Penzel and Mark Kriegsmann and David Reuß and Peter Schirmacher and Albrecht Stenzinger and P. Federspil and Wilko Weichert and Hanno Glimm and Stefan Fröhling},
  title = {{Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma}},
  journal = {Annals},
  year = {2016},
  doi = {10.1093/annonc/mdw446},
}

Loading related content...

Figure